FIELD: medicine.
SUBSTANCE: invention relates to the field of biotechnology, specifically to vaccines that contain antigens and adjuvant, which can be used in medicine. Recombinantly, an adjuvant is obtained from the group of recombinant mistletoe lectins of white, without glycosylation, which is used in the vaccine, which in turn is used as a medicament and composition.
EFFECT: invention makes it possible to obtain an effective vaccine containing one antigen or more and at least one adjuvant.
13 cl, 8 dwg, 2 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITIONS FOR THERAPEUTIC APPLICATION | 2004 |
|
RU2362586C2 |
IMMUNOSTIMULATING OLIGONUCLEOTIDES | 2009 |
|
RU2477753C2 |
VACCINE COMPOSITION POTENTIATED WITH DNA AND ANTIGEN COMBINATION | 2002 |
|
RU2294212C2 |
IMMUNOSTIMULATORY OLIGONUCLEOTIDES | 2012 |
|
RU2610690C2 |
AGENTS AND METHODS OF TREATING HEPATITIS B VIRUS | 2017 |
|
RU2740802C2 |
IMPROVED IMMUNOLOGICAL COMPOSITION | 2012 |
|
RU2664730C2 |
METHODS OF MALARIA VACCINATION | 2003 |
|
RU2356577C9 |
IMMUNOGENIC SUBSTANCES CONTAINING ADJUVANT OF POLYINOSINE ACID AND POLYCYTIDYLIC ACID | 2006 |
|
RU2462264C2 |
COMPOSITION FOR STIMULATING DENDRITIC CELL MATURATION, CONTAINING HYBRID PROTEIN RV2299C/ESAT-6 | 2017 |
|
RU2733886C2 |
PHARMACEUTICAL COMPOSITION FOR PREVENTING AND/OR TREATING HIV DISEASE IN HUMANS | 2012 |
|
RU2609769C2 |
Authors
Dates
2018-08-17—Published
2012-06-27—Filed